17beta-estradiol Signaling via Estrogen Receptor Alpha-36 Enhances Survival and Invasion of ERalpha-negative Breast Cancer Cells

被引：0
|
作者：
Chaudhri, R. A. [1 ]
Cuenca, N. [2 ]
Hadadi, A. [1 ]
Schwartz, Z. [2 ]
Boyan, B. D. [2 ]
机构：
[1] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70697-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 44 条
  • [41] Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways
    Hwang, Kyung-A
    Park, Min-Ah
    Kang, Nam-Hee
    Yi, Bo-Rim
    Hyun, Sang-Hwan
    Jeung, Eui-Bae
    Choi, Kyung-Chul
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 272 (03) : 637 - 646
  • [42] 17-β-Estradiol Inhibits Transforming Growth Factor-β Signaling and Function in Breast Cancer Cells via Activation of Extracellular Signal-Regulated Kinase through the G Protein-Coupled Receptor 30
    Kleuser, Burkhard
    Malek, Daniela
    Gust, Ronald
    Pertz, Heinz H.
    Potteck, Henrik
    MOLECULAR PHARMACOLOGY, 2008, 74 (06) : 1533 - 1543
  • [43] BINDING CHARACTERISTICS AND BIOLOGICAL-ACTIVITY OF 17-ALPHA-[I-125]IODOVINYL-11-BETA-METHOXYESTRADIOL, AN ESTROGEN RECEPTOR-BINDING RADIOPHARMACEUTICAL, IN HUMAN-BREAST CANCER-CELLS (MCF-7)
    MCMANAWAY, ME
    JAGODA, EM
    ECKELMAN, WC
    LARSON, SM
    FRANCIS, BE
    GIBSON, RE
    REBA, RC
    LIPPMAN, ME
    CANCER RESEARCH, 1986, 46 (05) : 2386 - 2389
  • [44] Positron emission tomography with 2-[F-18]fluoro-2-deoxy-D-glucose and 16 alpha-[F-18]fluoro-17 beta-estradiol in breast cancer: Correlation with estrogen receptor status and response to systemic therapy
    Mortimer, JE
    Dehdashti, F
    Siegel, BA
    Katzenellenbogen, JA
    Fracasso, P
    Welch, MJ
    CLINICAL CANCER RESEARCH, 1996, 2 (06) : 933 - 939
12345